This class action lawsuit is challenging the FDA’s approval of statin drugs. The lawsuit involves a class of more than twenty-five thousand individuals who believe that the FDA did not properly evaluate the health risks associated with these drugs. The class action lawsuit was filed on behalf of those who have experienced, either directly or indirectly, the side effects of these drugs. These include cardiac arrest, rashes, cognitive impairment, gastrointestinal complications, paralysis, and more.
One class of drugs is state A which is given to people with high cholesterol and to those at risk for cardiovascular disease. The drug is also prescribed for patients undergoing liver transplant. According to the World Health Organization (WHO), this class of drugs can cause heart attack and stroke. Statin A and other similar drugs have been linked to an increased risk of heart failure, a condition that ultimately leads to death.
The plaintiffs in the lawsuit are asking for compensation for suffering, disability, loss of enjoyment, and funeral expenses that have resulted from these drugs. The FDA claims that it was not negligent in approving state A. The courts, however, are considering different factors when deciding whether or not the FDA was at fault. One factor is how the FDA approved the drug. The manufacturer of state A had a contract with the Food and Drug Administration that dictating exactly how the drug would be approved. Other factors considered by the courts include the fact that the manufacturer knew of the risks of heart problems even before the FDA approved it and still went ahead with the release of the drug.
The FDA has also been accused of trying to cover up the link between statin use and various side effects. Several class action lawsuits have been filed in the past few years as a result of those links. An article published by the Wall Street Journal in 2021 described a study that was performed on more than one thousand men that were undergoing surgery. The study showed a twenty fold increase in strokes that were caused by the use of statins. Although the Wall Street Journal report reported that the class action lawsuit would probably not be successful, other news sources have since reported that there is a strong possibility of the lawsuit being successful.
The FDA has released statements claiming that the class action lawsuit against statin drugs would be pointless. The FDA contends that all of the studies that have been done on the subject so far have been either inconclusive or flawed in some way. They claim that all but one of the studies was either not adequately controlled or did not test the proper groups of people. As the FDA points out, it does not have the power to stop drug companies from releasing certain medications if research shows that they are dangerous. If a doctor prescribes a medication for a patient, he or she has the authority to make that decision. That is why the FDA must rely on doctors and institutions outside of the FDA to test drugs.
The FDA’s statements come at a time when more individuals are using statins to lower their cholesterol levels. The lawsuit may just be the beginning, and if it is successful, doctors could be sued for prescribing these drugs without first conducting adequate tests. The class action lawsuit against statin drugs represents the first time that this has been seen. As we have mentioned previously, there are many lawsuits currently pending in courts all across the country. If you feel that you were the result of a defected drug, you should speak with a qualified personal injury attorney immediately. A good lawyer will be able to determine whether or not your case has a solid chance of winning, and will help you move forward with it.